Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

334
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
The Micturition Reflex01:26

The Micturition Reflex

3.1K
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
3.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

377
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

367
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
367
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

381
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

289
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-Wide Survey for Microdeletions or -Duplications in 155 Patients with Lower Urinary Tract Obstructions (LUTO).

Genes·2021
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.4K

Pharmacotherapy for Pediatric Neurogenic Bladder.

Paweł Kroll1,2

  • 1Neuro-urology Unit, Pediatric Surgery and Urology Clinic, Ul. Pamiątkowa 2/42, 61-512, Poznań, Poland. pawelkroll.poczta@gmail.com.

Paediatric Drugs
|July 17, 2017
PubMed
Summary

Neurogenic bladder (NB) management in children focuses on protecting the urinary tract and improving continence. Conservative treatments like clean intermittent catheterization and medications aim for safe bladder pressures and reliable emptying.

More Related Videos

Isolation and Culture of Primary Neurons and Glia from Adult Rat Urinary Bladder
06:18

Isolation and Culture of Primary Neurons and Glia from Adult Rat Urinary Bladder

Published on: May 23, 2020

4.3K
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.9K

Related Experiment Videos

Last Updated: Feb 26, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.4K
Isolation and Culture of Primary Neurons and Glia from Adult Rat Urinary Bladder
06:18

Isolation and Culture of Primary Neurons and Glia from Adult Rat Urinary Bladder

Published on: May 23, 2020

4.3K
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.9K

Area of Science:

  • Pediatric Urology
  • Neuro-Urology

Background:

  • Neurogenic bladder (NB) is a broad term encompassing various bladder dysfunction types.
  • Dysraphic malformations are the leading cause of NB in pediatric populations.
  • Urodynamic evaluation is crucial for diagnosing NB and guiding treatment strategies.

Purpose of the Study:

  • To outline the diagnostic and therapeutic approaches for neurogenic bladder in children.
  • To highlight the primary goals of urologic treatment for pediatric NB patients.
  • To discuss conservative management options for functional bladder disorders.

Main Methods:

  • Urodynamic investigations to identify high intravesical pressure during storage and urination.
  • Conservative treatment strategies including clean intermittent catheterization (CIC).
  • Pharmacological management of functional bladder disorders.

Main Results:

  • High intravesical pressure during storage and urination are critical concerns in pediatric NB.
  • Conservative management aims to protect the urinary tract and achieve continence.
  • Clean intermittent catheterization and pharmacotherapy are key conservative treatments.

Conclusions:

  • Effective management of pediatric neurogenic bladder requires addressing high bladder pressures and ensuring reliable bladder emptying.
  • Conservative treatments are the mainstay, focusing on safety and continence.
  • While medications are used, official approvals for infants and young children are lacking.